PITTSBURGH and TOKYO, Oct. 9, 2024 /PRNewswire/ -- Viatris Inc. (VTRS) (NASDAQ: VTRS), a global healthcare company, today announced positive top-line results of its Phase 3 study (B2411367) in Japan ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback